Garrison Louis P, Hartgers-Gubbels Elisabeth Sophia, Chambers Michael
School of Pharmacy, University of Washington, Seattle, WA, USA.
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Int J Gen Med. 2022 Nov 23;15:8217-8224. doi: 10.2147/IJGM.S392906. eCollection 2022.
What other aspects of value may be relevant? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Lou Garrison about the societal perspective on value of healthcare interventions. Prof. Garrison is Professor Emeritus in The Comparative Health Outcomes, Policy, and Economics institute (CHOICE) in the School of Pharmacy at the University of Washington. Lou is past president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and he is currently co-chair of its Policy Outlook Committee. Going beyond the "conventional" elements of value assessment, Prof. Garrison highlights which additional impacts may be at play. He shares his concept of the "Value Flower", explaining elements such as insurance value and scientific spill-over.
还有哪些价值方面可能相关呢？在本期《价值内幕》播客中，主持人迈克·钱伯斯与卢·加里森教授探讨了医疗保健干预措施价值的社会视角。加里森教授是华盛顿大学药学院比较健康结果、政策与经济研究所（CHOICE）的名誉教授。卢曾是国际药物经济学与成果研究协会（ISPOR）的主席，目前是该协会政策展望委员会的联合主席。超越价值评估的“传统”要素，加里森教授强调了可能起作用的其他影响。他分享了他的“价值之花”概念，解释了保险价值和科学溢出等要素。
